CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,200 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02069509
NCT02069509N/ACompleted

Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)

European Friedreich's Ataxia Consortium for Translational Studies·observational·Posted Feb 24, 2014·Updated Oct 3, 2025

In Brief

An observational study for Friedreich's Ataxia. Completed, enrolled 1,200 participants across 16 sites in 10 countries.

Detailed Summary

This is a multi-centre, multi-national, prospective, observational study of Friedreich's Ataxia (FRDA) with a control group to: * obtain natural history data on individuals affected by FRDA * relate clinical assessments and results from proteomic analyses * expedite identification and recruitment of participants for clinical trials * develop and validate sensitive and reliable outcome measures for detecting onset and change over the natural course of FRDA which may also be potential outcome measures for use in future clinical trials and clinical care * plan for future research studies

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesAustria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Spain, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 24, 2014
Enrollment StartMay 1, 2010
Primary CompletionDec 1, 2024
TodayJul 2, 2026
Enrollment to primary: 14.6 yearsPosted 12.4 years ago